BioSpace News Archive

Business

Cerebain Biotech to Initiate Search for Contract Research Organization

Cerebain Biotech (OTCQB: CBBT) today announced that the company intends to initiate the search process to partner with a Contract Research Organization (CRO).

March 1, 2018
·
2 min read
Drug Development

Biohaven Announces Positive Results From Bioequivalence Study With Sublingual Rimegepant Zydis® Orally Dissolving Tablet

Rimegepant is a small molecule, oral, calcitonin gene-related peptide receptor antagonist currently in two pivotal Phase 3 trials for the acute treatment of migraine using a tablet formulation.

March 1, 2018
·
7 min read
Business

BostonSight® And CoolDoctors, Inc. Announce Collaboration

BostonSight to implement PeerMed, a peer-to-peer telemedicine platform developed by CoolDoctors.

March 1, 2018
·
2 min read
Job Trends

Take Control of Your Kidney Health During National Kidney Month

DaVita Kidney Care offers educational resources for kidney disease awareness.

March 1, 2018
·
4 min read
Business

Alkermes Appoints James Robinson as President and Chief Operating Officer

Mr. Robinson will lead Alkermes’ global Commercial, Operations, Business Development and Human Resources functions as the company prepares for the expansion of its commercial portfolio and builds the organization for its next stage of growth.

March 1, 2018
·
4 min read
Business

Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation

Dr. Prause has a successful track record of leading BEST through a significant expansion of its business in the last decade, with a focus on customer needs, productivity, quality and innovation.

March 1, 2018
·
2 min read
Business

Healthcare Technology Partnership Formed to Bring Patient-Centric Data Integrity to Health Information Exchanges

4medica and Zen Healthcare IT team up to enable HIEs, PDMP programs, payers, labs and providers with accurate, longitudinal views of patient health.

March 1, 2018
·
4 min read
Pharm Country

Amneal Launches Generic for Tamiflu® Oral Suspension

The powder finished dosage form is made in the U.S.A. and packaged in bottles providing 60 mL of usable volume after constitution.

March 1, 2018
·
2 min read
Biotech Bay

Helix Announces First Close of $200 Million in Financing to Drive Innovation in Personal Genomics

DFJ Growth is leading the Series B financing which includes participation from all founding investors, including Illumina, Kleiner Perkins Caufield Byers, Mayo Clinic, Sutter Hill Ventures, and Warburg Pincus.

March 1, 2018
·
4 min read
Drug Development

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 1 Trial of Oral KORSUVA™

Study to evaluate Peptelligence®-Engineered Oral CR845 (CR845/difelikefalin) in Chronic Liver Disease Patients

March 1, 2018
·
4 min read